Duchenne Muscular Dystrophy Treatment Market

Global Market Study on Duchenne Muscular Dystrophy: Europe to Lead the Global Market in Terms of Revenue during 2017 - 2026

Duchenne Muscular Dystrophy market is segmented by Product Type that is NSAIDs, Corticosteroids and by therapy that is Mutation Suppression and Exon Skipping Approach.

  • January-2018
  • PMRREP12475
  • 170 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

Table of Contents

1. Global Economic Outlook

2. Global Duchenne Muscular Dystrophy Market - Executive Summary

3. Global Duchenne Muscular Dystrophy Market Overview
     3.1. Introduction
            3.1.1. Global Duchenne Muscular Dystrophy Market Taxonomy
            3.1.2. Global Duchenne Muscular Dystrophy Market Definition
     3.2. Global Duchenne Muscular Dystrophy Market Size (US$ Mn) and Forecast, 2012-2026
            3.2.1. Global Duchenne Muscular Dystrophy Market Y-o-Y Growth
     3.3. Global Duchenne Muscular Dystrophy Market Dynamics
     3.4. Supply Chain
     3.5. Epidemiology
     3.6. Arrival of New Treatments
     3.7. Pipeline Assessment
     3.8. Prevalence of males with Duchenne and Becker Muscular Dystrophies
     3.9. Undergoing Studies on Products
     3.10. PESTLE Analysis
     3.11. Product Lifecycle
     3.12. Key Participants Market Presence (Intensity Map) By Region

4. Global Duchenne Muscular Dystrophy Market Analysis and Forecast 2012-2026 
     4.1. Global Duchenne Muscular Dystrophy Market Size and Forecast By Product Type, 2012-2026
            4.1.1. NSAIDs Market Size and Forecast, 2012-2026
                     4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.1.2. Market Share Comparison, By Region
                     4.1.1.3. Y-o-Y growth Comparison, By Region
            4.1.2. Corticosteroids Market Size and Forecast, 2012-2026
                     4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.2.2. Market Share Comparison, By Region
                     4.1.2.3. Y-o-Y growth Comparison, By Region
            4.1.3. Other Product Types Market Size and Forecast, 2012-2026
                     4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.3.2. Market Share Comparison, By Region
                     4.1.3.3. Y-o-Y growth Comparison, By Region
     4.2. Global Duchenne Muscular Dystrophy Market Size and Forecast By Distribution Channel, 2012-2026
            4.2.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
                     4.2.1.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.1.2. Market Share Comparison, By Region
                     4.2.1.3. Y-o-Y growth Comparison, By Region
            4.2.2. Retail Pharmacies Market Size and Forecast, 2012-2026
                     4.2.2.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.2.2. Market Share Comparison, By Region
                     4.2.2.3. Y-o-Y growth Comparison, By Region
            4.2.3. Online Pharmacies Market Size and Forecast, 2012-2026
                     4.2.3.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.3.2. Market Share Comparison, By Region
                     4.2.3.3. Y-o-Y growth Comparison, By Region
     4.3. Global Duchenne Muscular Dystrophy Market Size and Forecast By Therapy, 2012-2026
            4.3.1. Mutation suppression Market Size and Forecast, 2012-2026
                     4.3.1.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.1.2. Market Share Comparison, By Region
                     4.3.1.3. Y-o-Y growth Comparison, By Region
            4.3.2. Exon skipping approach Market Size and Forecast, 2012-2026
                     4.3.2.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.2.2. Market Share Comparison, By Region
                     4.3.2.3. Y-o-Y growth Comparison, By Region
            4.3.3. others Market Size and Forecast, 2012-2026
                     4.3.3.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.3.2. Market Share Comparison, By Region
                     4.3.3.3. Y-o-Y growth Comparison, By Region

5. North America Duchenne Muscular Dystrophy Market Size and Forecast, 2012-2026
     5.1. North America Outlook 
     5.2. North America Parent Market Outlook 
     5.3. North America Target Market Outlook 
     5.4. Revenue (US$ Mn) Comparison, By Country 
            5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
            5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
     5.5. Revenue (US$ Mn) Comparison, By Product Type 
     5.6. Revenue (US$ Mn) Comparison, By Distribution Channel
     5.7. Revenue (US$ Mn) Comparison, By Therapy

6. Latin America Duchenne Muscular Dystrophy Market Size and Forecast, 2012-2026
     6.1. Latin America Outlook 
     6.2. Latin America Parent Market Outlook 
     6.3. Latin America Target Market Outlook 
     6.4. Revenue (US$ Mn) Comparison, By Country 
            6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
            6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
            6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
     6.5. Revenue (US$ Mn) Comparison, By Product Type 
     6.6. Revenue (US$ Mn) Comparison, By Distribution Channel
     6.7. Revenue (US$ Mn) Comparison, By Therapy

7. Europe Duchenne Muscular Dystrophy Market Size and Forecast, 2012-2026
     7.1. Europe Outlook 
     7.2. Europe Parent Market Outlook 
     7.3. Europe Target Market Outlook 
     7.4. Revenue (US$ Mn) Comparison, By Country 
            7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
            7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
            7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
            7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
            7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
            7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
     7.5. Revenue (US$ Mn) Comparison, By Product Type 
     7.6. Revenue (US$ Mn) Comparison, By Distribution Channel
     7.7. Revenue (US$ Mn) Comparison, By Therapy

8. Japan Duchenne Muscular Dystrophy Market Size and Forecast, 2012-2026
     8.1. Japan Outlook 
     8.2. Japan Parent Market Outlook 
     8.3. Japan Target Market Outlook 
     8.4. Revenue (US$ Mn) Comparison, By Country 
            8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
     8.5. Revenue (US$ Mn) Comparison, By Product Type 
     8.6. Revenue (US$ Mn) Comparison, By Distribution Channel
     8.7. Revenue (US$ Mn) Comparison, By Therapy

9. APEJ Duchenne Muscular Dystrophy Market Size and Forecast, 2012-2026
     9.1. APEJ Outlook 
     9.2. APEJ Parent Market Outlook 
     9.3. APEJ Target Market Outlook 
     9.4. Revenue (US$ Mn) Comparison, By Country 
            9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
            9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
            9.4.3. Indonesia Market Size and Forecast (US$ Mn), 2012-2026
            9.4.4. South Korea Market Size and Forecast (US$ Mn), 2012-2026
            9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
            9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
     9.5. Revenue (US$ Mn) Comparison, By Product Type 
     9.6. Revenue (US$ Mn) Comparison, By Distribution Channel
     9.7. Revenue (US$ Mn) Comparison, By Therapy

10. MEA Duchenne Muscular Dystrophy Market Size and Forecast, 2012-2026
     10.1. MEA Outlook 
     10.2. MEA Parent Market Outlook 
     10.3. MEA Target Market Outlook 
     10.4. Revenue (US$ Mn) Comparison, By Country 
            10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
            10.4.2. Israel Market Size and Forecast (US$ Mn), 2012-2026
            10.4.3. Turkey Market Size and Forecast (US$ Mn), 2012-2026
            10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
     10.5. Revenue (US$ Mn) Comparison, By Product Type 
     10.6. Revenue (US$ Mn) Comparison, By Distribution Channel
     10.7. Revenue (US$ Mn) Comparison, By Therapy

11. Global Duchenne Muscular Dystrophy Market Company Share, Competition Landscape and Company Profiles
     11.1. Company Share Analysis
     11.2. Competition Landscape
     11.3. Company Profiles
            11.3.1. Sarepta Therapeutics, Inc
            11.3.2. Santhera Pharmaceuticals
            11.3.3. PTC Therapeutics
            11.3.4. Summit Therapeutics plc
            11.3.5. FibroGen, Inc
            11.3.6. ITALFARMACO S.p.A.

12. Research Methodology

13. Disclaimer

Find Out More about the Report Coverage

List of Tables

List of Tables

TABLE 1 Global Duchenne Muscular Dystrophy Market Value (US$ Mn), 2012-2017
TABLE 2 Global Duchenne Muscular Dystrophy Market Value (US$ Mn), 2018-2026
TABLE 3 Global Duchenne Muscular Dystrophy Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global NSAIDs Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global NSAIDs Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global NSAIDs Segment Market Share, By Region 2012-2017
TABLE 7 Global NSAIDs Segment Market Share, By Region 2018-2026
TABLE 8 Global NSAIDs Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Corticosteroids Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Corticosteroids Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Corticosteroids Segment Market Share, By Region 2012-2017
TABLE 12 Global Corticosteroids Segment Market Share, By Region 2018-2026
TABLE 13 Global Corticosteroids Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Other Products Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Other Products Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Other Products Segment Market Share, By Region 2012-2017
TABLE 17 Global Other Products Segment Market Share, By Region 2018-2026
TABLE 18 Global Other Products Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
TABLE 22 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
TABLE 23 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Retail Pharmacies Segment Market Share, By Region 2012-2017
TABLE 27 Global Retail Pharmacies Segment Market Share, By Region 2018-2026
TABLE 28 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Online Pharmacies Segment Market Share, By Region 2012-2017
TABLE 32 Global Online Pharmacies Segment Market Share, By Region 2018-2026
TABLE 33 Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Mutation Suppression Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Mutation Suppression Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Mutation Suppression Segment Market Share, By Region 2012-2017
TABLE 37 Global Mutation Suppression Segment Market Share, By Region 2018-2026
TABLE 38 Global Mutation Suppression Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Exon Skipping Approach Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Exon Skipping Approach Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Exon Skipping Approach Segment Market Share, By Region 2012-2017
TABLE 42 Global Exon Skipping Approach Segment Market Share, By Region 2018-2026
TABLE 43 Global Exon Skipping Approach Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Others Therapies Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Others Therapies Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Others Therapies Segment Market Share, By Region 2012-2017
TABLE 47 Global Others Therapies Segment Market Share, By Region 2018-2026
TABLE 48 Global Others Therapies Segment Y-o-Y, By Region 2017-2026
TABLE 49 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2012-2017
TABLE 50 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2018-2026
TABLE 51 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2012-2017
TABLE 52 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2018-2026
TABLE 53 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2012-2017
TABLE 54 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2018-2026
TABLE 55 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2012-2017
TABLE 56 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2018-2026
TABLE 57 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2012-2017
TABLE 58 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2018-2026
TABLE 59 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2012-2017
TABLE 60 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2018-2026
TABLE 61 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2012-2017
TABLE 62 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2018-2026
TABLE 63 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2012-2017
TABLE 64 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2018-2026
TABLE 65 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2012-2017
TABLE 66 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2018-2026
TABLE 67 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2012-2017
TABLE 68 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2018-2026
TABLE 69 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2012-2017
TABLE 70 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2018-2026
TABLE 71 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2012-2017
TABLE 72 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2018-2026
TABLE 73 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2012-2017
TABLE 74 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2018-2026
TABLE 75 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2012-2017
TABLE 76 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2018-2026
TABLE 77 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2012-2017
TABLE 78 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2018-2026
TABLE 79 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2012-2017
TABLE 80 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2018-2026
TABLE 81 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2012-2017
TABLE 82 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2018-2026
TABLE 83 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2012-2017
TABLE 84 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2018-2026
TABLE 85 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2012-2017
TABLE 86 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2018-2026
TABLE 87 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2012-2017
TABLE 88 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2018-2026
TABLE 89 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2012-2017
TABLE 90 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2018-2026
TABLE 91 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2012-2017
TABLE 92 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2018-2026
TABLE 93 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2012-2017
TABLE 94 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2018-2026
TABLE 95 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2012-2017
TABLE 96 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2018-2026

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

List of Figures

FIG. 1 Global Duchenne Muscular Dystrophy Market Value (US$ Mn), 2012-2017
FIG. 2 Global Duchenne Muscular Dystrophy Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Duchenne Muscular Dystrophy Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global NSAIDs Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global NSAIDs Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global NSAIDs Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Corticosteroids Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Corticosteroids Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Corticosteroids Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Other Products Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Other Products Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Other Products Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Mutation Suppression Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Mutation Suppression Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Mutation Suppression Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Exon Skipping Approach Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Exon Skipping Approach Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Exon Skipping Approach Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Others Therapies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Others Therapies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Others Therapies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2012-2017
FIG. 32 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2018-2026
FIG. 33 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2012-2017
FIG. 34 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2018-2026
FIG. 35 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2012-2017
FIG. 36 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2018-2026
FIG. 37 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2012-2017
FIG. 38 North America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2018-2026
FIG. 39 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2012-2017
FIG. 40 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2018-2026
FIG. 41 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2012-2017
FIG. 42 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2018-2026
FIG. 43 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2012-2017
FIG. 44 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2018-2026
FIG. 45 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2012-2017
FIG. 46 Latin America Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2018-2026
FIG. 47 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2012-2017
FIG. 48 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2018-2026
FIG. 49 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2012-2017
FIG. 50 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2018-2026
FIG. 51 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2012-2017
FIG. 52 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2018-2026
FIG. 53 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2012-2017
FIG. 54 Europe Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2018-2026
FIG. 55 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2012-2017
FIG. 56 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2018-2026
FIG. 57 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2012-2017
FIG. 58 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2018-2026
FIG. 59 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2012-2017
FIG. 60 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2018-2026
FIG. 61 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2012-2017
FIG. 62 Japan Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2018-2026
FIG. 63 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2012-2017
FIG. 64 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2018-2026
FIG. 65 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2012-2017
FIG. 66 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2018-2026
FIG. 67 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2012-2017
FIG. 68 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2018-2026
FIG. 69 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2012-2017
FIG. 70 APEJ Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2018-2026
FIG. 71 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2012-2017
FIG. 72 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Country 2018-2026
FIG. 73 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2012-2017
FIG. 74 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Product Type 2018-2026
FIG. 75 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2012-2017
FIG. 76 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Distribution Channel2018-2026
FIG. 77 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2012-2017
FIG. 78 MEA Duchenne Muscular Dystrophy Market Value (US$ Mn), By Therapy 2018-2026

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Description

Global Duchenne Muscular Dystrophy Market- Overview

Duchenne Muscular Dystrophy (DMD) is one of the most common types of genetic disorder that results in muscle degeneration. Currently there is no curative treatment for DMD, however, various organizations are investing in the research and development, in order to find an effective treatment for DMD. Gene therapy as the treatment for DMD is in an early stage of development.

The U.S. Food and Drugs Administration (FDA) in 2015 published guidelines for developing a drug for duchenne muscular dystrophy. Hence, these guidelines are expected to contribute towards new drug development to treat duchenne muscular dystrophy. Most of the DMD disorders can be detected during pregnancy, technically advanced devices are being developed for muscle biopsy test and prenatal tests for diagnosis. Also, small drugs for downstream defects are in clinical trials. However, lack of standardization to measure efficacy across all the stages of DMD and the high cost of novel drugs are hampering the growth of the global duchenne muscular dystrophy market.

Global Duchenne Muscular Dystrophy Market- Research Methodology

The report on the global duchenne muscular dystrophy market gives important perceptions on the overall market. The report offers critical insights focusing on the financial and technical details of the market. The market research report aims to provide key trends, various driving factors, opportunities in the market and factors hampering the market growth. The worldwide duchenne muscular dystrophy market analysis report includes market overview, growth, demand and research on the performance of the market in major regions across the globe. 

Both primary and secondary research was done by the expert analysts to provide a forecast on the market including revenue, CAGR, and year-on-year growth along with the information that will impact the market in the long run. The primary research was done by conducting interviews with market experts and details provided by them were crosschecked with valid sources. While, financial reports_bk_01_01_2020, annual reports_bk_01_01_2020 of the key companies and investor presentation formed the part of the secondary research.

The report also comprises SWOT analysis, Porter’s Five Force analysis. The report also provides regional overview along with market segmentation along with the details on the most attractive segments in the global duchenne muscular dystrophy market.

The report also provides competitive landscape including profiles of the key players operating in the global duchenne muscular dystrophy market. The report offers details on the key players including financial overview, company overview, product portfolio, key developments and long-term and short-term strategies by businesses. 

The global duchenne muscular dystrophy market is segmented on the basis of product type, distribution channel, therapy, and region. On the basis of product type, the market is segmented into NSAIDs, Corticosteroids, and other products. By distribution channel, the market segmentation includes Hospital Pharmacies, Retail Pharmacies, and online pharmacies.

Based on the therapy, the market is segmented into Mutation Suppression, Exon Skipping Approach, and other therapies. The global duchenne muscular dystrophy market segmented on the basis of region includes Europe, Japan, Latin America, Asia Pacific Excluding Japan (APEJ), North America, and the Middle East and Africa (MEA).

Recommendations

Dearomatic Solvents Market

The global de-aromatic solvents market is estimated to expand at a CAGR of more than 6% over the forecast period of 2021-2031..

Behenyl Alcohol Market

The behenyl alcohol market has seen steady demand from the cosmetics industry. Moreover, globally, per capita consumption of cosmetics is increasing at a rate of 3.4% per year.

Bismuth Market

Global bismuth market is estimated reach around US$ 225 Mn in 2016 and is projected to expand at a moderate single-digit CAGR in terms of value from 2016-2024.

Methyl Ethyl Ketone Market

The expected value of the global MEK market is expected to be US$ 800.2 Mn in 2018 and the market is estimated to reach US$ 1,055.6 Mn by the end of forecast period..

Our Clients

Our Clients